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Fulminant
Supraglottitis from
Neisseria 
meningitidis
To the Editor: A 68-year-old
Caucasian woman with non–insulin-
dependent diabetes mellitus, hyper-
tension, and peripheral vascular dis-
ease sought treatment at an emer-
gency department after experiencing
2 days of pharyngitis and 1 day of
fatigue and dysphagia for solid food.
The morning of admission she noted
dysphagia for solid food and liquids,
dysphonia, severe anterior neck pain,
neck swelling and erythema, dyspnea,
and a temperature of 102.3°F (39°C).
A computed tomographic (CT) scan
demonstrated substantial neck soft tis-
sue edema and narrowing of the
oropharynx and hypopharynx. She
received single doses of intravenous
ampicillin/sulbactam, clindamycin,
dexamethasone (10 mg), and methyl-
prednisolone (125 mg) before being
evacuated by air to our intensive care
unit (ICU) at Walter Reed Army
Medical Center. Intravenous ampi-
cillin/sulbactam, 3 g every 6 hours,
and clindamycin, 900 mg every 8
hours, were continued after the trans-
fer. Two doses of intravenous van-
comycin, 1 g every 12 hours, were
given before vancomycin was discon-
tinued. Results of laboratory studies
were the following: leukocyte count
13.3/mm3 (71% polymorphonuclear
leukocytes, 18% bands) and normal
hematocrit, platelet count, blood urea
nitrogen and creatinine concentra-
tions, and liver-associated enzymes.
A marker pen was used to track
the rapid advance of erythema
overnight from her anterior, inferior
chin to the top of her breasts (Figure).
The infectious disease service was
consulted the next morning. When she
was examined, her condition had
improved; she had normal vital signs,
a slightly hoarse voice, and the ability
to swallow some saliva. She had no
headache or meningismus. The chest
erythema was receding. Oral exami-
nation demonstrated erythema and an
abrasion in the posterior pharynx. Her
tongue was not elevated and her uvula
was midline. Anterior firm edema
without crepitus extended from her
chin to the mid-neck. Results of her
examination were otherwise unre-
markable. The infectious disease con-
sultant recommended restarting a
course of vancomycin and discontinu-
ing clindamycin.
A follow-up CT scan with con-
trast demonstrated anterior cervical
soft tissue edema and patent airway
with surrounding abnormal thickness
and soft tissue density. No abscess or
clot was seen. Endoscopic examina-
tion in the ICU showed diffuse erythe-
ma and generalized supraglottic
edema affecting mostly the epiglottis
and arytenoids. Dental examination
demonstrated no acute pathologic fea-
tures. Blood cultures at our hospital
yielded no growth, and throat culture
was negative for group Astreptococci.
The patient recovered without
requiring intubation (Figure). On the
day of discharge, a blood culture from
the referring hospital’s emergency
department was reported to be posi-
tive for Neisseria meningitidis,
serogroup Y. Immediate family mem-
bers and the otolaryngologists who
conducted the endoscopic examina-
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tion were given postexposure prophy-
laxis. The patient also received termi-
nal prophylaxis. Results of a screen-
ing CH50 for terminal complement
deficiency were normal.
This patient’s condition is consis-
tent with fulminant meningococcal
supraglottitis. Supraglottitis implies
involvement of the epiglottis and sur-
rounding structures and is more com-
monly used to describe adult infection
than is epiglottitis (1). Epiglottitis has
become more common in adults than
in children since the introduction of
the  Haemophilus influenzae type b
vaccine. Other organisms responsible
for epiglottitis in adults include H.
influenzae,  H. parainfluenzae, pneu-
mococci, Staphylococcus aureus, and
group A streptococci (2).
Despite its propensity to colonize
the upper respiratory tract, N. meningi-
tidis has rarely been identified as a
cause of supraglottitis or other deep
neck infections. Only 6 cases have
been reported, the first in 1995 (3–8).
Previously reported cases were equal-
ly apportioned by sex, and patients
were 44 to 95 years of age (3–8).
Including our patient, 3 of 7 were dia-
betic (6,7). None showed evidence of
meningitis or fulminant meningococ-
cemia, but all had fever, pharyngitis,
and airway compromise. Five required
airway intervention: 3 intubations and
2 urgent tracheostomies. Two received
steroids (3,4), a 54-year-old man
required urgent tracheostomy before
receiving steroids, and a 60-year-old
man’s condition “deteriorated rapid-
ly,” but the report does not indicate the
interval between receipt of steroids
and intubation. Although steroids have
been used, their benefit is unproven,
and no controlled clinical trials have
been conducted (9).
Blood cultures have been positive
from all reported case-patients. Two
isolates were typed as serogroup B, 4
as serogroup Y, and the serotype of 1
was unreported. Meningococcal
strains causing supraglottitis appear to
be more locally aggressive but cause
less disseminated disease, possibly
due to decreased tropism for endothe-
lial cells (8).
To our knowledge, ours is the sec-
ond case of meningococcal supraglot-
titis reported with severe neck edema
and cellulitis; a 44-year-old woman in
a prior review had features similar to
our patient (8). An 81-year-old woman
with diabetes was noted to have “red-
dish swelling” on the right side of the
neck (7), but little was described
beyond that. All 3 had serogroup Y
infection. We wondered whether
serogroup Y might have a propensity
to cause cellulitis; however, a review
of 10 cases of meningococcal cellulitis
included patients with multiple
serogroups: C (4 cases), B (2 cases), Y
(2 cases), and unknown (2 cases) (10).
N. meningitidis may cause supra-
glottitis more frequently than is rec-
ognized (3). Timely drawing of blood
cultures in relation to administration
of antimicrobial drugs is most likely
to identify this pathogen in this set-
ting. Because of its public health
implications and potential for rapid
progression to airway compromise, N.
meningitidis should be considered
among the differential diagnoses of
supraglottitis/epiglottitis. 
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Figure. Top: anterior and lateral views of patient on day 1 of receiving antimicrobial drugs,
demonstrating neck erythema and edema. Bottom: anterior and lateral views of patient on
day 8 of receiving antimicrobial drugs, demonstrating resolution of neck erythema and
edema.LETTERS
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gyrA Mutations in
Fluoroquinolone-
resistant
Clostridium difficile
PCR-027 
To the Editor: Clostridium diffi-
cile is the most common cause of bac-
terial diarrhea in hospitalized patients
(1). Antimicrobial drug therapy is the
most important risk factor associated
with the acquistion of C. difficile, and
several antimicrobial agents including
clindamycin, amoxicillin, and cepha-
lo-sporins have been particularly
associated with C. difficile infection
(2). Acquisition of resistance to clin-
damycin is considered 1 mechanism
whereby clonal strains emerge and
predominate in healthcare environ-
ments (3). Historically, fluoro-
quinolone antimicrobial agents were
considered low risk for C. difficile–
associated-disease; however, recent
studies indicate a shift in the risk asso-
ciated with their use (4). Furthermore,
recent outbreaks in Canada and the
United States have been associated
with fluoroquinolone exposure (4).
Recently, several C. difficile out-
breaks due to PCR ribotype 027
(PCR-027) and associated with
increased disease severity and death
have been reported worldwide (4).
This strain type contains the genes for
binary toxin and has an 18-bp deletion
and a frameshift mutation in tcdC
hypothesized to result in deregulated
expression of toxins A and B. These
strains produce 16× more toxin A and
23× more toxin B in vitro than toxino-
type 0 strains (5). These isolates
demonstrate universal high-level
resistance to fluoroquinolones in con-
trast to that of PCR 027 isolates col-
lected before 2001 (4).
We report the mechanism of fluo-
roquinolone resistance in a cluster (n =
5) of Irish PCR-027 C. difficile iso-
lates that were characterized by using
toxinotyping and 16–23S ribotyping.
Amplification with PCR and sequenc-
ing was used to identify the binary
toxin gene (cdtB) and an 18-bp dele-
tion and a frameshift mutation at posi-
tion 117 in the tcdC gene. Anti-
microbial susceptibility to 5 fluoro-
quinolone antimicrobial drugs was
determined with E-tests (AB-Biodisk,
Solna, Sweden). The quinolone-resist-
ance–determining region (QRDR) of
gyrA and gyrB was amplified by PCR
and characterized. The nucleotide
sequence data for partial sequences of
the  gyrA gene were submitted to
GenBank and assigned accession nos.
DQ821481, DQ821482, DQ821483,
and DQ821484.
PCR ribotyping profiles identified
1 cluster of C. difficile PCR-027 with
clinical isolates that showed indistin-
guishable profiles to the control 027
strain. PCR identified the cdtB, an 18-
bp deletion, and a frameshift mutation
at position 117 in the tcdC gene in all
5 isolates. These strains were univer-
sally resistant to the fluoroquinolones
tested (ofloxacin, ciprofloxacin, levo-
floxacin, moxifloxacin, and gatiflo-
xacin, respectively, MIC >32 µg/mL
[Table]). Control isolates were suscep-
tible to moxifloxacin and gatifloxacin
(MICs 0.3, 0.2 µg/mL, respectively);
however, these strains had reduced
susceptibility to levofloxacin (MIC
3 µg/mL) and were resistant to cipro-
floxacin and oflo-xacin (Table).
Sequence analysis determined that all
5 PCR-027 isolates had a single transi-
tion mutation (C to T), resulting in the
amino acid substitution Thr-82-Ile in
gyrA (Table). No amino acid substitu-
tions were found in the QRDR of gyrB
(data not shown).
Mutations in the active site or the
QRDR of DNA gyrase and topoiso-
merase IV have been associated with
increased resistance to fluoro-
quinolones in several bacteria (6). This
report identifies for the first time a
mutation in gyrA that is associated
with high-level resistance to fluoro-
quinolones in C. difficile PCR-027. In
Escherichia coli, amino acid substitu-
tions that occur at Ser-83 in gyrA have
been associated with fluoroquinolone
resistance (6). Thr-82 in C. difficile
corresponds to Ser-83 in E. coli. Thr-
to-Ile amino acid substitutions corre-
sponding to Ser-83 have been associ-
ated with fluoroquinolone resistance
in several bacteria, including
Pseudomonas aeruginosa,  Entero-
bacter aerogenes,  Campylobacter
jejuni, and C. difficile (6). Ackermann
et al. described 2 mutations in gyrA
that resulted in an amino acid substitu-
tion corresponding to codon 83 in E.
coli. Thirteen of the 18 C. difficile iso-
lates had the Thr-82-Ile substitution,
and 1 strain had a Thr-82-Val substitu-
tion (7). Dridi et al. described this Thr-
82-Ile GyrA substitution in 6 resistant
C. difficile strains corresponding to 3
serogroups, H1, A9, and 1C (8).
Early studies investigating fluo-
roquinolone antimicrobial agents
suggested that most C. difficile iso-
lates were susceptible to these drugs.